PubMed:10318905 / 938-1127 JSONTXT

{"project":"PMID_GLOBAL","denotations":[{"id":"T11","span":{"begin":40,"end":43},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":173,"end":188},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"0012041"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"0008315"}],"text":"Furthermore, we found this HER2/Neu --\u003e MAP kinase --\u003e AR-ARAs --\u003e PSA pathway could not be blocked completely by hydroxyflutamide, an antiandrogen used in the treatment of prostate cancer."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":189},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, we found this HER2/Neu --\u003e MAP kinase --\u003e AR-ARAs --\u003e PSA pathway could not be blocked completely by hydroxyflutamide, an antiandrogen used in the treatment of prostate cancer."}

{"project":"DisGeNET","denotations":[{"id":"T20","span":{"begin":67,"end":70},"obj":"gene:354"},{"id":"T21","span":{"begin":173,"end":188},"obj":"disease:C0600139"},{"id":"T22","span":{"begin":67,"end":70},"obj":"gene:354"},{"id":"T23","span":{"begin":173,"end":188},"obj":"disease:C0376358"}],"relations":[{"id":"R11","pred":"associated_with","subj":"T20","obj":"T21"},{"id":"R12","pred":"associated_with","subj":"T22","obj":"T23"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Furthermore, we found this HER2/Neu --\u003e MAP kinase --\u003e AR-ARAs --\u003e PSA pathway could not be blocked completely by hydroxyflutamide, an antiandrogen used in the treatment of prostate cancer."}

{"project":"PubmedHPO","denotations":[{"id":"T8","span":{"begin":173,"end":188},"obj":"HP_0012125"},{"id":"T9","span":{"begin":182,"end":188},"obj":"HP_0002664"}],"text":"Furthermore, we found this HER2/Neu --\u003e MAP kinase --\u003e AR-ARAs --\u003e PSA pathway could not be blocked completely by hydroxyflutamide, an antiandrogen used in the treatment of prostate cancer."}